Glucocorticoids and insulin resistance: Old hormones, new targets

Clinical Science

Volumn 96, Issue 5, 1999, Pages 513-523

  Andrews, Robert C ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Adipose tissue; Glucocorticoid hormones; Glucocorticoid receptors; Gluconeogenesis; Hydroxysteroid dehydrogenases; Insulin

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; HYDROCORTISONE; INSULIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CUSHING SYNDROME; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER METABOLISM; METABOLIC REGULATION; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TISSUE SPECIFICITY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; CARDIOVASCULAR DISEASES; GLUCOSE; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; INSULIN RESISTANCE; LIVER; MODELS, BIOLOGICAL; OBESITY; RISK FACTORS;

EID: 0032936343     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19980388     Document Type: Review

References (103)

1. 1 Reaven, G. M. and Hoffman, B. B. (1987) A role for insulin in the aetiology and course of hypertension? Lancet ii, 435-437
2. 2 Barker, D. J. P., Osmond, C., Golding, J., Kuh, D. and Wadsworth, M. E. J. (1989) Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. Br. Med. J. 298, 564-567
3. 3 Phillips, D. I. W., Barker, D. J. P., Hales, C. N., Hirst, S. and Osmond, C. (1994) Thinness at birth and insulin resistance in adult life. Diabetologia 37, 150-154
4. 4 Bjorntorp, P. (1991) Visceral fat accumulation: the missing link between psychosocial factors and cardiovascular disease? J. Intern. Med. 230, 195-201
5. 5 Panza, J. A., Casino, P. R., Kilcoyne, C. M. and Quyyumi, A. A. (1994) Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J. Am. Coll. Cardiol. 23, 1610-1616
6. 6 Dunaif, A., Scott, D., Finegood, D., Quintana, B. and Whitcomb, R. (1996) The insulin-sensitising agent troglitazone improves metabolic and reproductive abnormalities in the poiycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81, 3299-3306
7. 7 Baynes, K. C., Whitehead, J., Krook, A. and O'Rahilly, S. (1997) Molecular mechanisms of inherited insulin resistance. Q. J. Med. 90, 557-562
8. 8 Ferrannini, E. and Mari, A. (1998) How to measure insulin sensitivity. J. Hypertens. 16, 895-906
9. 9 Fery, F. (1994) Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting nyperglycaemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting. J. Clin. Endocrinol. Metab. 78, 536-542
10. 10 Ferrannini, E., Natali, A., Capaldo, B., Lehtovirta, M., Jacob, S. and Yki-Jarvinen, H. (1997) Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension 30, 1144-1149
11. 11 Yoshimura, R., Araki, E., Ura, S. et al. (1997) Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding site result in impaired function at different steps of IRS-1 signaling. Diabetes 46, 929-936
12. 12 Dallman, M. F., Strack, A. M., Akana, S. F. et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol. 14, 303-347
13. 13 Dinneen, S., Alzaid, A., Miles, J. and Rizza, R. (1993) Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans. J. Clin. Invest. 92, 2283-2290
14. 14 Rooney, D. P., Neely, R. D. G., Cullen, C., Ennis, C. N., Sheridan, B. and Atkinson, A. B. (1994) The effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin action. J. Clin. Endocrinol. Metab. 77, 1180-1183
15. 15 Rizza, R. A., Mandarino, L. J. and Gerich, J. (1982) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J. Clin. Endocrinol. Metab. 54, 131-138
16. 16 Chavez, M., Seeley, R. J., Green, P. K., Wilkinson, C. W., Schwartz, M. W. and Woods, S. C. (1997) Adrenalectomy increases sensitivity to central insulin. Physiol. Behav. 62, 631-634
17. 17 Ling, Z.-C., Khan, A., Delaunay, F. et al. (1998) Increased glucocorticoid sensitivity in islet beta-cells: effects on glucose 6-phosphatase, glucose cycling and insulin release. Diabetologia 41, 634-639
18. 18 Delaunay, F., Khan, A., Cintra, A. et al. (1997) Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest. 100, 2094-2098
19. 19 Lambillotte, C., Gilon, P. and Henquin, J.-C. (1997) Direct glucocorticoid inhibition of insulin secretion: an in vitro study of dexamethasone effects in mouse islets. J. Clin. Invest. 99, 414-423
20. 20 Stubbs, M. and York, D. A. (1991) Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat. Int. J. Obes. 15, 547-553
21. 21 Ross, E. J. and Linch, D. C. (1982) Cushing's syndrome -killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet 2, 646-649
22. 22 Kahn, C. R., Goldfine, I. D., Neville, D. M. and De Meyts, P. (1978) Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone. Endocrinology (Baltimore) 103, 1054-1066
23. 23 de Pirro, R., Bertoli, A., Fusco, A., Testa, I., Greco, A. V. and Lauro, R. (1980) Effect of dexamethasone and cortisone on insulin receptors in normal human male. J. Clin. Endocrinol. Metab. 51, 503-507
24. 24 Beck-Nielsen, H., de Pirro, R. and Pedersen, O. (1980) Prednisone increases the number of insulin receptors on monocytes from normal subjects. J. Clin. Endocrinol. Metab. 50, 1-4
25. 25 Pagano, G., Cavallo-Perin, P., Cassader, M. et al. (1983) An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J. Clin. Invest. 72, 1814-1820
26. 26 Fantus, I. G., Ryan, J., Hizuka, N. and Gorden, P. (1981) The effect of glucocorticoids on the insulin receptor: an in vivo and in vitro study. J. Clin. Endocrinol. Metab. 52, 953-960
27. 27 Giorgino, F., Almahfouz, A., Goodyear, L. J. and Smith, R. J. (1993) Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J. Clin. Invest. 91, 2020-2030
28. 28 O'Rahilly, S., Krook, A., Morgan, R., Rees, A., Flier, J. S. and Moller, D. E. (1992) Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh Type 2 (non-insulin-dependent) diabetic population. Diabetologia 35, 486-489
29. 29 Oda, N., Nakai, A., Mokuno, T. et al. (1995) Dexamethasone-induced changes in glucose transporter 4 in rat heart muscle, skeletal muscle and adipocytes. Eur. J. Endocrinol. 133, 121-126
30. 30 Coderre, L., Vallega, G. A., Pilch, P. F. and Chipkin, S. R. (1996) In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am. J. Physiol. 271, E643-E648
31. 31 Owen, O. E. and Cahill, Jr., G. F. (1973) Metabolic effects of exogenous glucocorticoids in fasted man. J. Clin. Invest. 52, 2596-2605
32. 32 Weinstein, S. P., Paquin, T., Pritsker, A. and Haber, R. S. (1995) Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin-and non-insulin-related stimuli. Diabetes 44, 441-445
33. 33 Dimitriadis, G., Leighton, B., Parry-Billings, M. et al. (1997) Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem. J. 321, 707-712
34. 34 Boden, G. (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46, 3-10
35. 35 Petrie, J. R. and Donnelly, R. (1994) New pharmacological approaches to insulin and lipid metabolism. Drugs 47, 701-710
36. 36 Boden, G., Chen, X., Rosner, J. and Barton, M. (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44, 1239-1242
37. 37 Ekstrand, A., Saloranta, C., Ahonen, J., Gronhagen-Riska, C. and Groop, L. C. (1992) Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man. Metabolism 41, 692-697
38. 38 Guillaume-Gentil, C., Assimacopoulos-Jeannet, F. and Jeanrenaud, B. (1993) Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36, 899-906
39. 39 Haourigui, M., Vallette, G., Martin, M.-E., Sumida, C., Benassayag, C. and Nunez, E. A. (1994) In vivo effect of free fatty acids on the specific binding of glucocorticosteroids to corticosteroid binding globulin and liver receptors in immature rats. Steroids 59, 46-54
40. 40 Vallette, G., Vanet, A., Sumida, C. and Nunez, E. A. (1991) Modulatory effects of unsaturated fatty acids on the binding of glucocorticoids to rat liver glucocorticoid receptors. Endocrinology (Baltimore) 129, 1363-1369
41. 41 Kennedy, B., Elayan, H. and Ziegler, M. G. (1993) Glucocorticoid induction of epinephrine synthesizing enzyme in rat skeletal muscle and insulin resistance. J. Clin. Invest. 92, 303-307
42. 42 Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J., Caro, J. F. and Flier, J. S. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416-2422
43. 43 Ong, J. M., Simsolo, R. B., Saffari, B. and Kern, P. A. (1992) The regulation of lipoprotein lipase gene expression by dexamethasone in isolated rat adipocytes. Endocrinology (Baltimore) 130, 2310-2316
44. 44 Baron, A. D., Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A. and Brechtel, G. (1995) Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsivencss in lean humans. J. Clin. Invest. 96, 786-792
45. 45 Leung, W.-H., Lau, C.-P. and Wong, C.-K. (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 341, 1496-1500
46. 46 Panza, J. A., Quyyumi, A. A., Callahan, T. S. and Epstein, S. E. (1993) Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J. Am. Coll. Cardiol. 21, 1145-1151
47. 18F]fluoro-2-deoxy-D-glucose, and positron emission tomography. Diabetes 45, 1471-1477
48. 48 Walker, B. R., Swan, P. J. H., Phin, P. et al. (1995) Mechanisms of glucocorticoid-induced hypertension: inhibition of endothelium-dependent vasodilation in rat and human vessels. J. Endocrinol., 144 (Suppl.), OC34 (Abstract)
49. 49 Polonsky, K. S., Sturis, J. and Van Cauter, E. (1998) Temporal profiles and clinical significance of pulsatile insulin secretion. Horm. Res. 49, 178-184
50. 50 Hanson, R. W. and Reshef, L. (1997) Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66, 581-611
51. 51 Malerbi, D., Liberman, B., Giurno-Filho, A., Giannella-Neto, D. and Wajchenberg, B. L. (1988) Glucocorticoids and glucose metabolism: hepatic glucose production in untreated Addisonian patients and on two different levels of glucocorticoid administration. Clin. Endocrinol. 28, 415-422
52. 52 Wajngot, A., Khan, A., Giacca, A., Vranic, M. and Efendic, S. (1990) Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects. Am. J. Physiol. 259, E626-E632
53. 53 Arriza, J. L., Weinberger, C. and Cerelli, G. (1987) Cloning of human mineralocorticoid receptor complementary DNA; structural and functional kinship with the glucocorticoid receptor. Science (Washington DC) 237, 268-275
54. 54 Sheppard, K. and Funder, J. W. (1987) Mineralocorticoid specificity of renal type 1 receptors; in vivo binding studies. Am. J. Physiol. 252, E224-E229
55. 55 Krozowski, Z. S. and Funder, J. W. (1983) Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc. Natl. Acad. Sci. U.S.A. 80, 6056-6060
56. 56 Mune, T., Rogerson, F. M, Nikkila, H., Agarwal, A. K. and White, P. C. (1995) Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nature Genet. 10, 394-399
57. 57 Stewart, P. M., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. H. L. and Edwards, C. R. W. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii, 821-824
58. 58 Edwards, C. R. W., Stewart, P. M., Burt, D. et al. (1988) Localisation of 11β-Miydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet ii, 986-989
59. 59 Funder, J. W., Pearce, P. T., Smith, R. and Smith, A. I. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (Washington DC) 242, 583-585
60. 60 Stewart, P. M. and Sheppard, M. C. (1992) Novel aspects of hormone action: intracellular ligand supply and its control by a series of tissue specific enzymes. Mol. Cell. Endocrinol. 83, C13-C18
61. 61 Albiston, A. L., Obeyesekere, V. R., Smith, R. E. and Krozowski, Z. S. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105, R11-R17
62. +-dependem isoform of 11β-Miydroxysteroid dehydrogenase. Cloning and characterisation of cDNA from sheep kidney. J. Biol. Chem. 269, 25959-25962
63. 63 Agarwal, A. K., Monder, C., Eckstein, B. and White, P. C. (1989) Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J. Biol. Chem. 264, 18939-18943
64. 64 Low, S. C., Chapman, K. E., Edwards, C. R. W. and Seckl, J. R. (1994) 'Liver-type' 11β-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. J. Mol. Endocrinol. 13, 167-174
65. 65 Jamieson, P. M., Chapman, K. E., Edwards, C. R. W. and Seckl, J. R. (1995) 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology (Baltimore) 136, 4754-4761
66. 66 Ricketts, M. L., Shoesmith, K. J., Hewison, M., Strain, A., Eggo, M. C. and Stewart, P. M. (1998) Regulation of 11beta-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J. Endocrinol. 156, 159-168
67. 67 Bujalska, I. J., Kumar, S. and Stewart, P. M. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349, 1210-1213
68. 68 Napolitano, A., Voice, M. W., Edwards, C. W., Seckl, J. R. and Chapman, K. E. (1998) 11beta-Hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J. Steroid Biochem. Mol. Biol. 64, 251-260
69. 69 Jamieson, P. M., Walker, B. R., Chapman, K. E., Rossiter, S. and Seckl, J. R. (1997) 11β-Hydroxysteroid dehydrogenase type 1 is a predominant 11-reductase in intact perfused rat liver. J. Endocrinol. 152, OC8 (Abstract)
70. 70 Walker, B. R., Campbell, J. C., Fraser, R., Stewart, P. M. and Edwards, C. R. W. (1992) Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin. Endocrinol. (Oxford) 37, 483-492
71. 71 Stewart, P. M., Wallace, A. M., Atherden, S. M., Shearing, C. H. and Edwards, C. R. W. (1990) Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 78, 49-54
72. 72 Walker, B. R., Connacher, A. A., Lindsay, R. M., Webb, D. J. and Edwards, C. R. W. (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J. Clin. Endocrinol. Metab. 80, 3155-3159
73. 73 Low, S. C., Chapman, K. E., Edwards, C. R. W., Wells, T., Robinson, I. C. A. F. and Seckl, J. R. (1994) Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J. Endocrinol. 143, 541-548
74. 74 Jamieson, P. M., Nyirenda, M. J., Walker, B. R., Chapman, K. E. and Seckl, J. R. (1999) Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11β-hydroxysteroid dehydrogenase type 1. J. Endocrinol. in the press
75. 75 Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. et al. (1997) 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. Proc. Natl. Acad. Sci. U.S.A. 94, 14924-14929
76. 76 Hammami, M. M. and Siiteri, P. K. (1991) Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocrinol. Metab. 73, 326-334
77. 77 Benediktsson, R., Lindsay, R. S., Noble, J., Seckl, J. R. and Edwards, C. R. W. (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341, 339-341
78. 78 Lindsay, R. S., Lindsay, R. M., Waddell, B. J. and Seckl, J. R. (1996) Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39, 1299-1305
79. 79 Phillips, D. I. W., Barker, D. J. P., Fall, C. H. D. et al. (1998) Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J. Clin. Endocrinol. Metab. 83, 757-760
80. 80 Stolk, R. P., Lamberts, S. W. J., de Jong, F. H., Pols, H. A. P. and Grobbee, D. E. (1996) Gender differences in the associations between cortisol and insulin sensitivity in healthy subjects. J. Endocrinol. 149, 313-318
81. 81 Filipovsky, J., Ducimetiere, P., Eschwege, E., Richard, J. L., Rosselin, G. and Claude, J. R. (1996) The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J. Hypertens. 14, 229-235
82. 81a Reynolds, R. M., Bendall, H. E., Walker, B. R., Wood, P. J., Phillips, D. I. W. and Whorwood, C. B. (1998) Hyperactivity of the hypothalamic-pituitary-adrenal axis may mediate the link between impaired fetal growth and the insulin resistance syndrome. J. Endocrinol. 159 (suppl.), OC5 (Abstract)
83. 82 Walker, B. R., Phillips, D. I. W., Noon, J. P. et al. (1998) Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 31, 891-895
84. 83 Ljung, T., Andersson, B., Bengtsson, B., Bjorntorp, P. and Marin, P. (1996) Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obesity Res. 4, 277-282
85. 84 Andrew, R., Phillips, D. I. W. and Walker, B. R. (1998) Obesity and gender influence cortisol secretion and metabolism in man. J. Clin. Endocrinol. Metab. 83, 1806-1809
86. 85 Marin, P., Darin, M., Amemiya, T., Andersson, B., Jern, S. and Bjorntorp, P. (1992) Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 41, 882-886
87. 86 Pasquali, R., Cantobelli, S., Casimirri, F. et al. (1993) The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab. 77, 341-346
88. 87 Stewart, P. M., Shackleton, C. H. L., Beastall, G. H. and Edwards, C. R. W. (1990) 5alpha-reductase activity in polycystic ovarian syndrome. Lancet 335, 431-433
89. 88 Hautanen, A. and Adlercreutz, H. (1993) Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome. J. Intern. Med. 234, 461-469
90. 89 Rosmond, R., Dallman, M. F. and Bjorntorp, P. (1998) Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83, 1853-1859
91. 90 Walker, B. R., Best, R., Shackleton, C. H. L., Padfield, P. L. and Edwards, C. R. W. (1996) Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 27, 190-196
92. 91 Panarelli, M., Holloway, C. D., Fraser, R. et al. (1998) Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects, J. Clin. Endocrinol. Metab. 83, 1846-1852
93. 92 Watt, G. C. M., Harrap, S. B., Foy, C. J. W. et al. (1992) Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four corners approach to the identification of genetic determinants of blood pressure. J. Hypertens. 10, 473-482
94. 93 Weaver, J. U., Hitman, G. A. and Kopelman, P. G. (1992) An association between a Bell restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women. J. Mol. Endocrinol. 9, 295-300
95. 94 Mulatero, P., Panarelli, M., Schiavone, D. et al. (1997) Impaired cortisol binding to glucocorticoid receptors in hypertensive patients. Hypertension, 30, 1274-1278
96. 95 Nyirenda, M. J., Lindsay, R. S., Kenyon, C. J., Burchell, A. and Seckl, J. R. (1998) Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J. Clin. Invest. 101, 2174-2181
97. 96 Levitt, N. S., Holmes, M. C., Lindsay, R. S. and Seckl, J. R. (1996) Dexamethasone in the last week of pregnancy attenuates hippocampal giucocorticoid receptor gene expression ana elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64, 412-418
98. 97 Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L. and Edwards, C. R. W. (1993) Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. (Oxford) 39, 221-227
99. 98 Soro, A., Ingram, M. C., Tonolo, G., Glorioso, N. and Fraser, R. (1995) Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 25, 67-70
100. 99 Rodin, A., Thakkar, H., Taylor, N. and Clayton, R. (1994) Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11beta-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330, 460-465
101. 100 Quinones-Galvan, A. and Ferrannini, E. (1997) Renal effects of insulin in man. J. Nephrol. 10, 188-191
102. 101 Kumar, S., Durrington, P. N., O'Rahilly, S. et al. (1996) Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J. Clin. Endocrinol. Metab. 81, 3465-3468
103. 102 Bruning, J. C., Winnay, J., Bonner-Weir, S., Taylor, S. I., Accili, D. and Kahn, C. R. (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561-572